Physician profile
Samuel Ray Hiser
NPI 1760459648
$2,255.42
in general payments reported to CMS, 2019-2025
17 companies · $90.10 in 2025
The $90.10 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $328 · 2022: $1,053 · 2023: $784 · 2025: $90.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $842 · Education: $32.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $841.50 |
| Education | $32.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $802.20 | 2021-2023 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $298.26 | 2021-2023 | Tezspire |
| Mylan Specialty L.P. | $228.36 | 2021-2023 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $184.97 | 2022-2023 | Ofev |
| Regeneron Healthcare Solutions, INC. | $174.97 | 2022 | |
| Insmed, INC. | $169.82 | 2021-2023 | Arikayce |
| Grifols USA, LLC | $98.78 | 2022-2023 | Prolastin-C Liquid |
| Lilly USA, LLC | $90.10 | 2025 | Zepbound |
| Genzyme Corporation | $40.70 | 2022-2023 | |
| United Therapeutics Corporation | $38.52 | 2022-2023 | Tyvaso |
| Baxter Healthcare | $27.26 | 2023 | Hillrom - Life 2000 Ventilation System |
| Tactile Systems Technology INC | $20.76 | 2022 | |
| Amgen INC. | $18.38 | 2023 | Tezspire |
| Novartis Pharmaceuticals Corporation | $16.58 | 2023 | |
| La Jolla Pharmaceutical Company | $16.48 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $16.48 | 2023 | Xolair |
| Merck Sharp & Dohme LLC | $12.80 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Hiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.